TechNavio's analysts forecast the Global Multiple Sclerosis (MS) Therapeutics market to grow at a CAGR of 3.16 percent over the period 2012-2016. One of the key factors contributing to this market growth is the rising diagnosis and treatment rates. The Global MS Therapeutics market has also been witnessing the emergence of biomarkers. However, the lack of therapies available to manage the progression of the disease could pose a challenge to the growth of this market.
TechNavio's report, the Global Multiple Sclerosis (MS) Therapeutics Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the EMEA and APAC regions; it also covers the Global MS Therapeutics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this space include Bayer HealthCare AG, Biogen Idec Inc., Merck Serono SA, Novartis AG, and Teva Pharmaceutical Industries Ltd.
The other vendors mentioned in this report are AB Science, Abbvie Inc., Active Biotech AB, Astra Zeneca plc, Glaxo Smith Kline plc, Glenmark Pharmaceuticals Ltd., Hoffmann-La Roche Inc., and Sanofi SA.
Key questions answered in this report:
What will the market size be in 2016 and what will be the growth rate?
What are key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by key vendors?
What are the strengths and weaknesses of each of these key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details provided within the report.
01. Executive Summary
02. List of Abbreviations
03. Introduction
04. Market Research Methodology
Market Research Process
Research Design
Research Methodology
05. Scope of the Report
Market Overview
Product Offerings
06. Market Landscape
06.1 Global MS Market
Market Size and Forecast
06.2 MS Market in the US
Market Size and Forecast
06.3 MS Market in Europe
Market Size and Forecast
06.4 Five Forces Analysis
07. Geographical Segmentation
08. Rate of Incidence and Prevalence
09. Vendor Landscape
10. Buying Criteria
11. Market Growth Drivers
12. Drivers and their Impact
13. Market Challenges
14. Impact of Drivers and Challenges
15. Market Trends
15.1 Bayer HealthCare AG
Business Overview
Key Information
SWOT Analysis
15.2 Biogen Idec Inc.
Business Overview
Key Information
SWOT Analysis
15.3 Merck Serono SA
Business Overview
Key Information
SWOT Analysis
15.4 Novartis AG
Business Overview
Key Information
SWOT Analysis
15.5 Teva Pharmaceutical Industries Ltd.
Business Overview
Key Information
SWOT Analysis
16. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global MS Market 2012-2016 (US$ billion)
Exhibit 3: MS Market in the US 2012-2016 (US$ billion)
Exhibit 4: MS Market in Europe 2012-2016 (US$ billion)
Exhibit 5: Global MS Market by Geographical Segmentation 2012
Exhibit 6: Global MS Market by Vendor Segmentation 2012
Exhibit 7: Business Segmentation of Bayer HealthCare AG
Exhibit 8: Business Segmentation of Merck Serono SA
Exhibit 10: Business Segmentation of Novartis AG
Exhibit 12: Business Segmentation of Teva Pharmaceuticals Industries Ltd.
Contact us at the Consulting WP office nearest to you or submit a business inquiry online.
Subscribe to Our Newsletter
Published On : December 2019
$ 3600
Published On : December 2019
$ 3600